2022
DOI: 10.1016/j.jviromet.2021.114348
|View full text |Cite
|
Sign up to set email alerts
|

Optimisation of methodology for whole genome sequencing of Measles Virus directly from patient specimens

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
4
1

Relationship

1
4

Authors

Journals

citations
Cited by 9 publications
(4 citation statements)
references
References 26 publications
0
4
0
Order By: Relevance
“…[44] With this approach, coverage can be reduced by lower sample quality, lower viral load, and higher point mutations. [45, 46] In addition, our primers were designed using 2016 consensus sequences in the genome database, and might, therefore, be susceptible to viral evolution leading to amplicon dropouts. [44, 47] This underscores the need for continual refinement of tiled primers for optimal amplification of circulating virus strains, as documented during the COVID pandemic by the need to update ARTIC tiled primers for sequencing SARSCoV-2 genomes.…”
Section: Discussionmentioning
confidence: 99%
“…[44] With this approach, coverage can be reduced by lower sample quality, lower viral load, and higher point mutations. [45, 46] In addition, our primers were designed using 2016 consensus sequences in the genome database, and might, therefore, be susceptible to viral evolution leading to amplicon dropouts. [44, 47] This underscores the need for continual refinement of tiled primers for optimal amplification of circulating virus strains, as documented during the COVID pandemic by the need to update ARTIC tiled primers for sequencing SARSCoV-2 genomes.…”
Section: Discussionmentioning
confidence: 99%
“…For the whole N and HA sequences we have approximately 99.93% coverage and a depth of 10×, thus minimizing any technology bias. 13 Partial N (450 bp) and HA (1854 bp) consensus sequences (AC# OR224894 to OR224917) were used for genotyping using MEGA 7 14 according to CDC and WHO recommendations. 15,16…”
Section: Methodsmentioning
confidence: 99%
“…These samples were thus representative of the 12 weeks of the epidemic follow‐up and presented with a Ct ≤ 30 that allowed a clean sequencing with the MinION. For the whole N and HA sequences we have approximately 99.93% coverage and a depth of 10×, thus minimizing any technology bias 13 . Partial N (450 bp) and HA (1854 bp) consensus sequences (AC# OR224894 to OR224917) were used for genotyping using MEGA 7 14 according to CDC and WHO recommendations 15,16…”
Section: Methodsmentioning
confidence: 99%
“…Total nucleic acids from clinical specimens were extracted on the MagNA Pure 96 using the DNA and Viral NA large volume kit (catalog 06374891001, Roche), and for the isolate, the QIAamp Viral RNA kit (Qiagen catalog 52906). All next-generation sequencing (NGS) libraries were prepared as previously described and used a probe enrichment modification of the TruSeq DNA Nano LP kit (catalog 20016328 Illumina) ( 4 ). Libraries were paired-end sequenced on an Illumina MiSeq with a v3 reagent kit (catalog MS-102–3003).…”
Section: Announcementmentioning
confidence: 99%